Home › NCT07769151

BIO-FUNCTION for Prediction Non Relapse Mortality in Transplant and Cell Therapy

BIO-FUNCTION for NRM Prediction in SCTCT: Assessing Biological and Functional Reserve to Predict Non-Relapse Mortality in Stem Cell Transplant and Cell Therapy

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* patients \>18 year old planned for SCTCT

Exclusion Criteria:

* Pregnancy, prisoners , Patients with a serious medical or psychiatric illness likely to interfere with participation in this clinical study

About the study

The purpose of this research is test if combination of physical tests and blood tests drawn before SCTCT can predict NRM.

What is being tested

• blood sample to check CXCL9 pre stem cell transplant and cell therapy (diagnostic test)

Sponsor: Henry Ford Health System · Participants: 124 · Started: Sep 1, 2026

Contact the study team

• Shatha Farhan, MD · Phone: 3137133910

Official record on ClinicalTrials.gov — NCT07769151

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.